(Downloading may take up to 30 seconds.
If the slide opens in your browser, select File -> Save As to save it.)
Click on image to view larger version.

Fig. 3. Identification of an upstream Eomes retinal enhancer containing
Pou4f2-binding sites. (A,B) E14.5 retinal sections from
Pou4f2+/lacZ and Pou4f4lacZ/lacZ
embryos immunostained with anti-Eomes antibody and counterstained with
propidium iodide. (C) 20 kb Vista analysis of Eomes comparing
mouse, human, dog and rat genomes. Pou4f2-binding sites A and B are indicated
by arrowheads. (D) The DNA sequence of Pou4f2 sites A and B. The 2.8 kb
retinal enhancer fragment is indicated in red. (E) Transgenic embryos
carrying Eo2.8k-HSP68p-LacZ-pA construct stain positively in the retina and
limb (arrowheads). (F) Histological retinal section of
Eo2.8k-HSP68p-LacZ-pA E14.5 embryos shows lacZ expression in RGCs
within the NBL. lacZ-expressing cells co-localized with
Pou4f2-expressing cells, detected using anti-Pou4f2 antibody (G).
(H-K) GFP expression in Bac Eomes::GFP retinas. GFP fluorescence in
retinas from E14.5 (H) and E16.5 (J) embryos. There is intense
auto-fluorescence in retina pigment epithelia layer (RPE). Immunostaining
using Alexa-555-anti-GFP antibody on retinal sections from E14.5 (I) and E16.5
(K) embryos. Scale bars: 100 µm in B,G,K for A,B, F,G and H-K,
respectively.